NCT04872946

Brief Summary

The overall objective of this study is to assess how oral supplementation with Inner Calm and the use of topical Super Calm can affect the appearance of skin and inner wellness, such as redness, skin sensitivity, and reactionary skin.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 26, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 7, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 7, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 9, 2020

Completed
7 months until next milestone

First Posted

Study publicly available on registry

May 5, 2021

Completed
Last Updated

May 5, 2021

Status Verified

April 1, 2021

Enrollment Period

5 months

First QC Date

October 9, 2020

Last Update Submit

April 29, 2021

Conditions

Keywords

skindermatology

Outcome Measures

Primary Outcomes (2)

  • Changes in appearance of facial redness

    Photographic image analysis

    8 weeks

  • Changes in appearance of facial pigmentation

    Photographic image analysis

    8 weeks

Secondary Outcomes (8)

  • Changes in appearance of facial redness before and after treatment

    8 weeks

  • Subjective report of skin reactivity

    8 weeks

  • Subjective report of sleep quality and quantity

    8 weeks

  • Subjective report of mood and energy

    8 weeks

  • Subjective report of calmness of mind

    8 weeks

  • +3 more secondary outcomes

Study Arms (3)

InnerCalm+skin care

EXPERIMENTAL

An oral supplement and topical agent will be assigned.

Dietary Supplement: TeaOther: SerumOther: Moisturizer

InnerCalm only

EXPERIMENTAL

An oral supplement will be assigned.

Dietary Supplement: Tea

Skincare Only

EXPERIMENTAL

A topical agent only will be assigned.

Other: SerumOther: Moisturizer

Interventions

TeaDIETARY_SUPPLEMENT

Ashwagandha(Withania somnifera) root and leaf extract (32% Withania Oligosaccharides, 10% Withanolide Glycosides, 0.5% Withaferin A) 125 mg Saffron(Crocus Sativus) stigmas extract (3.48% Crocin and 0.03% Safranal) 28mg

InnerCalm onlyInnerCalm+skin care
SerumOTHER

Aqua/Water/Eau, Glycerin, Propanediol, Diheptyl Succinate, Caprylic/Capric Triglyceride, Lactococcus Ferment Lysate, Sorbitol, Dimethicone, Steareth-21, Octyldodecyl Neopentanoate, Sodium Polyacrylate, Steareth-2, Caprylyl Glycol, Hydrogenated Polydecene, Trideceth-6, Octyldodecanol, Panthenol, Sodium PCA, Azelaic Acid, Bisabolol, Capryloyl Glycerin/Sebacic Acid Copolymer, Centella Asiatica Leaf Extract, Agastache Mexicana Flower/Leaf/Stem Extract, Caprylhydroxamic Acid, Phytic Acid, Aminomethyl Propanol, Lactic Acid, Sodium Chloride, Phenoxyethanol, Sodium Benzoate.

InnerCalm+skin careSkincare Only

Aqua/Water/Eau, Glycerin, Diisopropyl Dimer Dilinoleate, Coco-Caprylate, Lactococcus Ferment Lysate, Myristyl Myristate, Dimethicone, Propanediol, Behenyl Alcohol, Glyceryl Stearate SE, Potassium Cetyl Phosphate, Palmitic Acid, Ammonium Acryloyldimethyltaurate/Beheneth-25 Methacrylate Crosspolymer, Myristyl Laurate, Caprylyl Glycol, Hydroxyethylcellulose, Myristic Acid, Tocopherol, Ethylhexylglycerin, Centella Asiatica Leaf Extract, Agastache Mexicana Flower/Leaf/Stem Extract, Helianthus Annuus (Sunflower) Seed Oil, Trisodium Ethylenediamine Disuccinate, Lactic Acid, Sodium Hydroxide, Sodium Phosphate, Disodium Phosphate, Sodium Chloride, t-Butyl Alcohol, Phenoxyethanol, Sodium Benzoate.

InnerCalm+skin careSkincare Only

Eligibility Criteria

Age18 Years - 55 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Women aged 18-55
  • Fitzpatrick skin type 1-4
  • Self-perception as sensitive skin

You may not qualify if:

  • Adults unable to consent
  • Individuals who are not yet adults (infants, children, teenagers)
  • Pregnant or breast-feeding women
  • Prisoners
  • Those who have used isotretinoin in the last 6 months
  • Those who have used products containing salicylic acid, beta hydroxyl acids or vitamins A, C, or E or topical retinoids or topical depigmenting agents (such as hydroquinone, kojic acid, azelaic acid, or others in opinion of the investigator) in the last 14 days
  • Those who are currently smoking or have smoked within the past 3 years.
  • Those who have had a recent surgical or cosmetic procedure in the last 3 months that can affect facial wrinkles, redness, or hyperpigmentation, such as botulinum toxin injections, chemical peels, laser-based therapies to the face, or face lift surgeries
  • Subjects with known allergy to any of the components of Inner Calm or Skin Calm
  • Those that are unwilling to discontinue use of any other nutritional supplements including antioxidants, herbs, or protein-based supplements for 2 weeks prior to and during their participation.
  • Subjects with a diagnosis of acne

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Integrative Skin Science and Research

Sacramento, California, 95815, United States

Location

MeSH Terms

Conditions

Skin Abnormalities

Interventions

Tea

Condition Hierarchy (Ancestors)

Congenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Plant PreparationsBiological ProductsComplex MixturesBeveragesDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Raja K Sivamani, MD

    Integrative Skin Science and Research Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 9, 2020

First Posted

May 5, 2021

Study Start

November 26, 2019

Primary Completion

May 7, 2020

Study Completion

May 7, 2020

Last Updated

May 5, 2021

Record last verified: 2021-04

Locations